Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

2.

S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase.

Saba JD, de la Garza-Rodea AS.

Biochim Biophys Acta. 2013 Jan;1831(1):167-75. doi: 10.1016/j.bbalip.2012.06.009. Epub 2012 Jun 28. Review.

3.

Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway.

Loh KC, Leong WI, Carlson ME, Oskouian B, Kumar A, Fyrst H, Zhang M, Proia RL, Hoffman EP, Saba JD.

PLoS One. 2012;7(5):e37218. doi: 10.1371/journal.pone.0037218. Epub 2012 May 14. Erratum in: PLoS One. 2012;7(6): doi/10.1371/annotation/7e7ac57d-30ae-4e49-9138-e3bdbe3491d2.

4.

Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression.

de la Garza-Rodea AS, Baldwin DM, Oskouian B, Place RF, Bandhuvula P, Kumar A, Saba JD.

FASEB J. 2014 Jan;28(1):506-19. doi: 10.1096/fj.13-233155. Epub 2013 Oct 24.

5.

Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.

Degagné E, Pandurangan A, Bandhuvula P, Kumar A, Eltanawy A, Zhang M, Yoshinaga Y, Nefedov M, de Jong PJ, Fong LG, Young SG, Bittman R, Ahmedi Y, Saba JD.

J Clin Invest. 2014 Dec;124(12):5368-84. doi: 10.1172/JCI74188. Epub 2014 Oct 27.

6.

Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells.

Zhang W, An J, Jawadi H, Siow DL, Lee JF, Zhao J, Gartung A, Maddipati KR, Honn KV, Wattenberg BW, Lee MJ.

Prostaglandins Other Lipid Mediat. 2013 Oct;106:62-71. doi: 10.1016/j.prostaglandins.2013.06.001. Epub 2013 Jun 11.

7.

Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis.

Kariya Y, Kihara A, Ikeda M, Kikuchi F, Nakamura S, Hashimoto S, Choi CH, Lee YM, Igarashi Y.

Genes Cells. 2005 Jun;10(6):605-15.

8.

Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Arikawa K, Takuwa N, Yamaguchi H, Sugimoto N, Kitayama J, Nagawa H, Takehara K, Takuwa Y.

J Biol Chem. 2003 Aug 29;278(35):32841-51. Epub 2003 Jun 16.

9.

Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction.

Klyachkin YM, Nagareddy PR, Ye S, Wysoczynski M, Asfour A, Gao E, Sunkara M, Brandon JA, Annabathula R, Ponnapureddy R, Solanki M, Pervaiz ZH, Smyth SS, Ratajczak MZ, Morris AJ, Abdel-Latif A.

Stem Cells Transl Med. 2015 Nov;4(11):1333-43. doi: 10.5966/sctm.2014-0273. Epub 2015 Sep 14.

10.

First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer.

Brizuela L, Ader I, Mazerolles C, Bocquet M, Malavaud B, Cuvillier O.

Mol Cancer Ther. 2012 Sep;11(9):1841-51. doi: 10.1158/1535-7163.MCT-12-0227. Epub 2012 Jul 10.

11.

Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor.

Donati C, Meacci E, Nuti F, Becciolini L, Farnararo M, Bruni P.

FASEB J. 2005 Mar;19(3):449-51. Epub 2004 Dec 29.

PMID:
15625079
12.

Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues.

Borowsky AD, Bandhuvula P, Kumar A, Yoshinaga Y, Nefedov M, Fong LG, Zhang M, Baridon B, Dillard L, de Jong P, Young SG, West DB, Saba JD.

J Lipid Res. 2012 Sep;53(9):1920-31. doi: 10.1194/jlr.M028084. Epub 2012 Jul 9.

13.

S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.

Bandhuvula P, Honbo N, Wang GY, Jin ZQ, Fyrst H, Zhang M, Borowsky AD, Dillard L, Karliner JS, Saba JD.

Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1753-61. doi: 10.1152/ajpheart.00946.2010. Epub 2011 Feb 18.

14.

Lyase to live by: sphingosine phosphate lyase as a therapeutic target.

Kumar A, Saba JD.

Expert Opin Ther Targets. 2009 Aug;13(8):1013-25. doi: 10.1517/14728220903039722. Review.

16.

Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation.

Colié S, Van Veldhoven PP, Kedjouar B, Bedia C, Albinet V, Sorli SC, Garcia V, Djavaheri-Mergny M, Bauvy C, Codogno P, Levade T, Andrieu-Abadie N.

Cancer Res. 2009 Dec 15;69(24):9346-53. doi: 10.1158/0008-5472.CAN-09-2198.

17.

Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm.

Kihara A, Ikeda M, Kariya Y, Lee EY, Lee YM, Igarashi Y.

J Biol Chem. 2003 Apr 18;278(16):14578-85. Epub 2003 Feb 12.

18.

Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again.

Oskouian B, Saba J.

Cell Cycle. 2007 Mar 1;6(5):522-7. Epub 2007 Mar 21. Review.

PMID:
17361098
19.

Stat3 signaling regulates embryonic stem cell fate in a dose-dependent manner.

Tai CI, Schulze EN, Ying QL.

Biol Open. 2014 Sep 19;3(10):958-65. doi: 10.1242/bio.20149514.

20.

Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.

Oskouian B, Sooriyakumaran P, Borowsky AD, Crans A, Dillard-Telm L, Tam YY, Bandhuvula P, Saba JD.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17384-9. Epub 2006 Nov 7.

Supplemental Content

Support Center